Seattle researchers uncover genetic drivers of aggressive prostate cancer; NCI awards $200K contract to BioMarker Strategies

> Researchers from the Fred Hutchinson Cancer Research Center and the University of Washington have found genetic triggers at play in aggressive forms of prostate cancer. Story

> The National Cancer Institute has awarded a $200,000 contract to BioMarker Strategies to fund the creation of a companion molecular diagnostic to match patients with the appropriate targeted cancer drugs. Report

> Researchers at the University of Cambridge have identified genes that could be used to guide treatment of patients with Crohn disease and ulcerative colitis. Item

> A group of scientists from UCLA and elsewhere have contributed to the discovery of gene variants that signal increased risk of schizophrenia and bipolar disorder. Release

Suggested Articles

Medtronic has expanded its portfolio aimed at improving the safety of head and neck surgeries, with a new acquisition and an FDA clearance.

By casting a broad, digital net to pick up the signs of coronavirus outbreaks, researchers hope to build an early warning system from wearable tech.

C2N Diagnostics launched a blood test that can identify the state of amyloid plaque in the brain, one of the hallmarks of Alzheimer's disease.